IRIS
SARACENI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 823
EU - Europa 366
AS - Asia 96
AF - Africa 1
Totale 1.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 822
IT - Italia 106
SE - Svezia 65
IE - Irlanda 48
UA - Ucraina 47
CN - Cina 43
DE - Germania 26
SG - Singapore 21
GB - Regno Unito 17
DK - Danimarca 16
FR - Francia 15
TR - Turchia 15
BE - Belgio 9
FI - Finlandia 9
IN - India 9
KR - Corea 7
PL - Polonia 4
CH - Svizzera 2
CA - Canada 1
JP - Giappone 1
NL - Olanda 1
NO - Norvegia 1
ZA - Sudafrica 1
Totale 1.286
Salva come PNG Salva come JPEG
Città #
Chandler 184
Ashburn 64
Des Moines 61
Fairfield 55
Jacksonville 51
Dublin 48
New York 36
Wilmington 31
Boardman 29
Centro 28
Redmond 24
Seattle 24
Lawrence 20
Princeton 20
Woodbridge 18
Cambridge 15
Houston 15
Ann Arbor 13
Turin 13
San Mateo 12
San Diego 11
Washington 10
Brussels 9
Los Angeles 9
Guangzhou 8
Beijing 7
Milan 7
Jesi 5
Civitanova Marche 4
Leawood 4
Marche 4
Mumbai 4
Palermo 4
Pune 4
Shanghai 4
Wuxi 4
Florence 3
Rome 3
Singapore 3
Wuhan 3
Ancona 2
Cremona 2
Fano 2
Helsinki 2
London 2
Prescot 2
Quanzhou 2
Zurich 2
Bologna 1
Chicago 1
Chiswick 1
Corridonia 1
Edinburgh 1
Falconara Marittima 1
Fuzhou 1
Heze 1
Hounslow 1
Jiaxing 1
Jinan 1
Jining 1
Johannesburg 1
Kagoya 1
Kilburn 1
Lequile 1
Manchester 1
Miami 1
Montesilvano 1
Montreal 1
New Bedfont 1
New Delhi 1
Norwalk 1
Oslo 1
Paris 1
Philadelphia 1
Porto Recanati 1
Portsmouth 1
Sant'angelo In Vado 1
Shenzhen 1
Southwark 1
Udine 1
Yiwu 1
Totale 920
Salva come PNG Salva come JPEG
Nome #
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 101
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 95
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 88
null 86
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 83
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 80
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 77
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 75
null 74
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 72
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 67
Mobilization policy in multiple myeloma: Minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean 65
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 62
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 60
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 47
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 43
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 38
null 37
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT) 37
Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study 30
null 10
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT 3
Editorial: Reviews in hematologic malignancies 3
Focus on: Prognostic scores to predict stem cell mobilization 2
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 2
Secondary Acute Myeloid Leukemia: Pathogenesis and Treatment 1
Totale 1.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.033
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202068 4 1 9 0 12 1 11 2 12 1 5 10
2020/2021214 13 18 22 24 21 4 11 20 20 22 22 17
2021/2022213 7 17 11 9 4 9 25 21 13 17 37 43
2022/2023471 44 55 29 39 39 103 1 24 88 3 35 11
2023/2024224 34 8 15 22 29 68 3 5 0 9 4 27
2024/202535 35 0 0 0 0 0 0 0 0 0 0 0
Totale 1.338